@cunjevoi
Hi there,
You are right in that Mesoblast’s MSCs can be allegeciacally introduced to patients without an immune response.
But Mesoblast’s MSCs also secrete proteins which reduces existing inflammation.
Check out Mesoblast’s website, and also all their clinical trials- one of the key benefits of MSC’s on all the diseases being treated is its ability to modulate the body’s immune response.
http://www.mesoblast.com/science/mesenchymal-lineage-cells
TEMCELL, page-14
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.105(8.37%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.23 | $1.14 | $9.583M | 8.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 25000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |